Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis

被引:1
作者
Watson, HR
Robb, R
Belcher, G
Belch, JJF
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland
[2] Takeda Europe, R&D Ctr, Drug Safety, Frankfurt, Germany
关键词
Raynaud's phenomenon; systemic sclerosis; season; temperature;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, Patients with systemic sclerosis (SSc) were assessed for 12 months to quantify the seasonal variation in Raynaud's phenomenon (RP) in patients with an underlying connective tissue disease. Methods. Eighteen patients with SSc (17 limited, 1 diffuse type) were studied. Raynaud's attacks were recorded in a daily diary for four 2-week periods at 3 month intervals, Daily number and duration of attacks and overall severity of RP were calculated for each 2-week period. Mean daily temperatures, measured and perceived, were obtained for each period. Results, In winter, patients had a mean of 2.9 attacks/day (SD +/- 1.1), daily duration 70 minutes (SD +/- 48) and a severity of score of 4.1 (SD +/- 2.0) out of 10. All 3 variables correlated with ambient outdoor temperature and varied significantly over the 12 months (p < 0.001) with mean reductions of 48, 50, and 56% respectively from winter to summer. Only 3 of 18 patients reported no attacks during the summer period. The mean measured and perceived outdoor temperatures increased from winter to summer by 10.6 and 14.3 degrees C, respectively. Conclusion. For patients with SSc, RP is a problem throughout the year. Symptoms may be reduced by about 50% in the summer months, but few patients experience complete relief.
引用
收藏
页码:1734 / 1737
页数:4
相关论文
共 50 条
  • [31] Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis
    Silveri, F
    De Angelis, R
    Poggi, A
    Muti, S
    Bonapace, G
    Argentati, F
    Cervini, C
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (05) : 290 - 296
  • [32] Effect of biofeedback and deep oscillation on Raynaud’s phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial
    Birte Sporbeck
    Kirsten Mathiske-Schmidt
    Silke Jahr
    Dörte Huscher
    Mike Becker
    Gabriela Riemekasten
    Ines Taufmann
    Gerd-Rüdiger Burmester
    Stephanie Pögel
    Anett Reisshauer
    Rheumatology International, 2012, 32 : 1469 - 1473
  • [33] Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial
    Sporbeck, Birte
    Mathiske-Schmidt, Kirsten
    Jahr, Silke
    Huscher, Doerte
    Becker, Mike
    Riemekasten, Gabriela
    Taufmann, Ines
    Burmester, Gerd-Ruediger
    Poegel, Stephanie
    Reisshauer, Anett
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (05) : 1469 - 1473
  • [34] Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: A multicentre, placebo-controlled, dose-comparison study
    Black, CM
    Halkier-Sorensen, L
    Belch, JJF
    Ullman, S
    Madhok, R
    Smit, AJ
    Banga, JD
    Watson, HR
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (09): : 952 - 960
  • [35] The frequency of Raynaud’s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
    Tracy M. Frech
    Maureen A. Murtaugh
    Megan Amuan
    Mary Jo Pugh
    BMC Rheumatology, 5
  • [36] The frequency of Raynaud's phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database
    Frech, Tracy M.
    Murtaugh, Maureen A.
    Amuan, Megan
    Pugh, Mary Jo
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [37] From Raynaud's Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
    Bellando-Randone, Silvia
    Matucci-Cerinic, Marco
    CURRENT RHEUMATOLOGY REVIEWS, 2013, 9 (04) : 245 - 248
  • [38] Efficacy of bosentan in the treatment of Raynaud's phenomenon in patients with systemic sclerosis never treated with prostanoids
    Parisi, S.
    Bruzzone, M.
    Di Vittorio, C. Centanaro
    Lagana, A.
    Peroni, C. L.
    Fusaro, E.
    REUMATISMO, 2013, 65 (06) : 286 - 291
  • [39] Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy
    Bukhari, M
    Hollis, S
    Moore, T
    Jayson, MIV
    Herrick, AL
    RHEUMATOLOGY, 2000, 39 (05) : 506 - 512
  • [40] Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon
    Bestetti, A
    Carola, F
    Conciato, L
    Marasini, B
    Tarolo, GL
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (01) : 77 - 84